DXCM - DexCom, Inc. Stock Price and Quote

DXCM [NASD]

Index	NDX, S&P 500	P/E	144.91	EPS (ttm)	0.80	Insider Own	0.10%	Shs Outstand	386.40M	Perf Week	-4.29%
Market Cap	45.01B	Forward P/E	80.05	EPS next Y	1.45	Insider Trans	-33.54%	Shs Float	384.65M	Perf Month	2.98%
Income	341.20M	PEG	4.74	EPS next Q	0.15	Inst Own	98.80%	Short Float / Ratio	3.27% / 5.05	Perf Quarter	2.19%
Sales	2.91B	P/S	15.47	EPS this Y	57.80%	Inst Trans	-0.35%	Short Interest	12.58M	Perf Half Y	41.73%
Book/sh	5.52	P/B	21.03	EPS next Y	40.10%	ROA	6.60%	Target Price	132.74	Perf Year	-5.29%
Cash/sh	6.33	P/C	18.33	EPS next 5Y	30.60%	ROE	16.20%	52W Range	66.89 - 134.76	Perf YTD	0.57%
Dividend	-	P/FCF	147.73	EPS past 5Y	37.80%	ROI	8.20%	52W High	-15.50%	Beta	1.16
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	32.30%	Gross Margin	65.20%	52W Low	70.24%	ATR	3.89
Employees	7500	Current Ratio	2.00	Sales Q/Q	16.80%	Oper. Margin	13.40%	RSI (14)	49.89	Volatility	2.75% 3.21%
Optionable	Yes	Debt/Eq	0.95	EPS Q/Q	15.90%	Profit Margin	11.70%	Rel Volume	0.42	Prev Close	116.07
Shortable	Yes	LT Debt/Eq	0.59	Earnings	Feb 09 AMC	Payout	0.00%	Avg Volume	2.49M	Price	113.88
Recom	1.70	SMA20	-0.43%	SMA50	1.84%	SMA200	14.40%	Volume	578,104	Change	-1.89%

Jan-26-23

Initiated

Wolfe Research

Outperform

$121

Oct-18-22

Initiated

Barclays

Equal Weight

$103

Oct-12-22

Initiated

Jefferies

Buy

$125

Jul-15-22

Initiated

Bernstein

Outperform

$105

Mar-02-22

Resumed

BofA Securities

Buy

$500

Feb-03-22

Upgrade

BTIG Research

Neutral → Buy

$535

Jan-19-22

Upgrade

Wells Fargo

Equal Weight → Overweight

$575

Jan-07-22

Upgrade

Guggenheim

Neutral → Buy

$580

Oct-18-21

Downgrade

Guggenheim

Buy → Neutral

Jul-21-21

Resumed

Cowen

Outperform

$540 → $525

Show Previous Ratings

Mar-25-23 05:41AM	Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend Motley Fool
Mar-24-23 12:10PM	Dexcom Stock Option Trade Could Return $465 While Risking Just $35 Investor's Business Daily
11:59AM	Dexcom (DXCM) Launches G6 Glucose Monitoring System in Canada Zacks
06:59AM	DexCom, Inc.'s (NASDAQ:DXCM) Stock Has Fared Decently: Is the Market Following Strong Financials? Simply Wall St.
Mar-23-23 09:53AM	Have $1,000? 2 Stock-Split Companies to Add to Your Buy Basket Right Now. Motley Fool
06:15PM	Loading…
Mar-21-23 06:15PM	DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know Zacks
06:00AM	Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors Business Wire
Mar-20-23 09:00AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises Zacks
02:15AM	Is DexCom (DXCM) Stock Undervalued? Insider Monkey
Mar-18-23 06:29PM	Why Nick Jonas is raising awareness for diabetes at SXSW Yahoo Finance Video
Mar-16-23 11:14AM	DexCom Stock Gets A Composite Rating Upgrade After 4 Up Days Investor's Business Daily
Mar-15-23 06:15PM	DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
Mar-13-23 07:30AM	DexCom Comments on SVB Relationship Business Wire
Mar-09-23 06:15PM	DexCom (DXCM) Stock Moves -0.59%: What You Should Know Zacks
09:53AM	2 Top Stocks to Buy in March and Hold Forever Motley Fool
08:00AM	Loading…
08:00AM	Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever Motley Fool
Mar-08-23 10:19PM	Analyst Report: DexCom, Inc. Morningstar Research
Mar-07-23 04:59AM	What Makes DexCom (DXCM) an Attractive Investment Bet? Insider Monkey
Mar-06-23 04:04PM	Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories Investor's Business Daily -7.87%
10:05AM	5 Stocks That Powered Nasdaq ETF Last Week Zacks
Mar-03-23 06:15PM	DexCom (DXCM) Gains But Lags Market: What You Should Know Zacks
02:38PM	Here's Why DexCom (NASDAQ:DXCM) Has Caught The Eye Of Investors Simply Wall St.
08:20AM	1 High-Flying Growth Stock With 19% Upside, According to Wall Street Motley Fool
Mar-02-23 04:04PM	Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices Investor's Business Daily +9.46%
05:05AM	Where to Invest $1,000 in a 2023 Nasdaq Bear Market Motley Fool
Feb-28-23 04:56PM	Billionaire Israel Englander Is Making Huge Bets on These 2 Strong Buy Stocks TipRanks
05:52AM	Should Abbott and DexCom Investors Be Worried About Apple's Latest News? Motley Fool
05:00AM	What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing? News Direct
Feb-24-23 09:45AM	Better Buy: Abbott Laboratories or DexCom Stock? Motley Fool
09:37AM	2 Stock-Split Stocks with Explosive Potential to Buy in 2023 Motley Fool
09:00AM	Loading…
Feb-23-23 09:00AM	Dexcom Announces Upcoming Conference Presentations Business Wire
Feb-22-23 04:04PM	Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple Investor's Business Daily
12:00AM	Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally Business Wire
Feb-21-23 09:01PM	Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore Business Wire
06:45AM	3 Healthcare Stocks to Buy and Hold for the Next 10 Years Motley Fool
Feb-20-23 09:00AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now Zacks
05:21AM	2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands Motley Fool
Feb-19-23 09:45AM	2 No-Brainer Growth Stocks to Buy Right Now Motley Fool
08:25AM	2 Healthcare Stocks You Can Buy and Hold for the Next Decade Motley Fool
Feb-18-23 09:04AM	Deere Leads 5 Stocks With Hot Products Near Buy Points Investor's Business Daily
Feb-17-23 12:37AM	Does DexCom (DXCM) Have a Long Runway for Growth? Insider Monkey
Feb-13-23 03:02PM	Dow Jones Leader Salesforce Headlines 4 Stocks In Or Near Buy Zone Investor's Business Daily
08:53AM	2 Growth Stocks That Could Help Make You a Fortune Motley Fool
08:30AM	Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch Business Wire
08:30AM	2 Top Healthcare Stocks to Buy for the Long Haul Motley Fool
Feb-11-23 07:35AM	DexCom Full Year 2022 Earnings: EPS Misses Expectations Simply Wall St.
Feb-10-23 04:59PM	IBD Stock Of The Day Dexcom Bounds Off A New Entry After Topping Bullish Calls Investor's Business Daily +9.93%
04:04PM	Dexcom, A Top 10% Profit Machine, Just Reported Skyrocketing Earnings Investor's Business Daily
08:52AM	DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong Zacks
Feb-09-23 11:34PM	Analyst Report: DexCom, Inc. Morningstar Research
09:30PM	DexCom (DXCM) Q4 2022 Earnings Call Transcript Motley Fool
05:15PM	DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates Zacks
04:13PM	Dexcom Advances On Fourth-Quarter Beat, Reiterates Its 2023 Sales Expectations Investor's Business Daily
04:03PM	Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results Business Wire
Feb-07-23 10:05AM	2 Stock-Split Stocks to Buy Without Hesitation in 2023 Motley Fool
Feb-06-23 09:42AM	DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-03-23 09:37AM	2 Unstoppable Growth Stocks to Buy in 2023 and Beyond Motley Fool
Feb-02-23 06:15PM	DexCom (DXCM) Gains But Lags Market: What You Should Know Zacks
Jan-27-23 06:15PM	DexCom (DXCM) Gains But Lags Market: What You Should Know Zacks
Jan-25-23 11:30AM	Masimo's (MASI) Patient Monitoring Devices Favored by New Study Zacks
06:39AM	Daily Vickers Top Buyers & Sellers for 01/25/2023 Argus Research
Jan-24-23 09:00AM	Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time Business Wire
Jan-20-23 06:15PM	DexCom (DXCM) Gains But Lags Market: What You Should Know Zacks
07:00AM	DexCom (DXCM) Stock Benefited from Multiple Tailwinds in Q4 Insider Monkey
05:10AM	2 No-Brainer Growth Stocks to Buy Right Now Motley Fool
Jan-17-23 06:00AM	Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program Business Wire
Jan-13-23 10:09AM	2 Best Stocks to Buy in January and Hold Forever Motley Fool
Jan-12-23 06:15PM	DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know Zacks
Jan-11-23 03:41PM	As Dexcom Settles, 2 Option Strategies Collect Premium, Minimize Risk Investor's Business Daily
10:30AM	Covid-19 Still a Problem for Health Stocks The Wall Street Journal
Jan-10-23 12:47PM	DexCom (DXCM) Announces Solid Preliminary Q4 Revenues Zacks
05:50AM	Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade Motley Fool
Jan-09-23 09:00AM	1 Top Growth Stock That Could Beat the Market In 2023 and Beyond Motley Fool
08:00AM	Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook Business Wire
08:00AM	Dexcom Appoints Teri Lawver as Chief Commercial Officer Business Wire
Jan-06-23 08:00AM	DexCom (NASDAQ:DXCM) shareholders have earned a 51% CAGR over the last five years Simply Wall St.
03:43AM	3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised) Zacks
Jan-05-23 11:57AM	3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio Zacks
Jan-03-23 09:00AM	Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference Business Wire
Dec-30-22 06:00PM	DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
10:35AM	Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic Motley Fool
Dec-28-22 06:15PM	DexCom (DXCM) Stock Moves -0.1%: What You Should Know Zacks
10:37AM	2 Growth Stocks to Invest $1,500 in Before the End of 2022 Motley Fool
Dec-22-22 06:00PM	DexCom (DXCM) Stock Moves -0.94%: What You Should Know Zacks
Dec-20-22 09:53AM	The Best Stocks to Invest $5,000 in Right Now Motley Fool
Dec-19-22 09:49AM	11 Best Medical Technology Stocks To Buy Insider Monkey
Dec-16-22 06:00PM	DexCom (DXCM) Dips More Than Broader Markets: What You Should Know Zacks
Dec-15-22 09:45AM	2 Breakout Growth Stocks to Buy for the Long Haul Motley Fool
Dec-14-22 10:03AM	3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio Zacks
Dec-12-22 08:00AM	Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience Business Wire
Dec-09-22 08:30AM	Have $1,000? 2 Smart Stocks to Buy in a Nasdaq Bear Market Motley Fool -5.06%
Dec-08-22 09:50AM	IBD Stock Of The Day Dexcom: How A Key FDA Decision Could Make It Actionable Investor's Business Daily
08:45AM	Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S. Business Wire
Dec-06-22 12:35PM	Dow Jones Leaders Caterpillar, Home Depot Headline These Best Stocks To Watch Investor's Business Daily
Dec-05-22 08:20AM	Dow Jones Futures Fall In Resilient Market Rally; Tesla Stock Falls On Production Cut Investor's Business Daily
07:13AM	Dow Jones Futures Fall, Oil Prices Pop In Resilient Market Rally; Tesla Falls On Production Cut Investor's Business Daily
Dec-02-22 05:08PM	Market Rally Resilient, But This Battle Continues; What To Do Now Investor's Business Daily
Dec-01-22 10:15AM	2 Monster Stocks to Buy Without Any Hesitation Motley Fool
10:07AM	The Best Stocks to Invest $20,000 in Right Now Motley Fool
05:23AM	3 Supercharged Growth Stocks to Buy for 2023 Motley Fool

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pacelli Steven Robert	EVP Managing Director Dexcom V	Mar 23	Sale	116.40	5,442	633,449	138,129	Mar 27 05:08 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Mar 16	Sale	115.00	2,303	264,845	33,569	Mar 17 04:14 PM
Stern Sadie	EVP Chief Human Resources Offi	Mar 14	Sale	111.86	393	43,961	83,645	Mar 15 04:03 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Mar 13	Sale	106.27	6,229	661,956	35,872	Mar 14 04:46 PM
Flynn Paul R	EVP Global Revenue	Mar 13	Sale	106.27	2,782	295,643	54,893	Mar 14 04:46 PM
Regan Barry J.	EVP Operations	Mar 13	Sale	106.27	2,010	213,603	70,472	Mar 14 04:46 PM
Leach Jacob Steven	EVP Chief Technology Officer	Mar 06	Sale	114.74	18,144	2,081,822	281,089	Mar 06 08:05 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Mar 06	Sale	114.40	226	25,854	26,536	Mar 06 08:04 PM
SAYER KEVIN R	President CEO and Chairman of	Mar 01	Sale	109.94	38,464	4,228,611	331,337	Mar 02 05:16 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Feb 23	Sale	111.64	412	45,996	136,464	Feb 23 06:34 PM
Sylvain Jereme M	EVP Chief Financial Officer	Feb 22	Sale	114.54	2,400	274,896	64,837	Feb 22 06:08 PM
SAYER KEVIN R	President CEO and Chairman of	Jan 30	Sale	106.15	56,844	6,034,123	369,801	Jan 31 04:07 PM
Regan Barry J.	EVP Operations	Jan 30	Sale	106.12	2,213	234,844	59,386	Jan 31 04:07 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jan 23	Sale	107.86	412	44,438	136,876	Jan 24 04:16 PM
SAYER KEVIN R	President CEO and Chairman of	Jan 20	Sale	105.75	45,607	4,822,872	426,645	Jan 24 04:17 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Dec 23	Sale	112.57	412	46,379	137,288	Dec 27 04:29 PM
Flynn Paul R	EVP Global Revenue	Dec 08	Sale	123.50	8,988	1,110,018	55,744	Dec 08 06:07 PM
Sylvain Jereme M	EVP Chief Financial Officer	Nov 21	Sale	112.62	2,400	270,288	67,237	Nov 22 06:25 PM
Dolan Matthew Vincent	SVP Corporate Strategy-Develop	Sep 01	Sale	81.63	5	408	26,536	Sep 06 09:33 AM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Aug 23	Sale	84.21	1,000	84,210	137,700	Aug 24 05:25 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jul 25	Sale	83.07	1,000	83,070	138,700	Jul 25 06:00 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Jun 23	Sale	72.55	1,000	72,550	139,700	Jun 27 04:46 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jun 06	Sale	301.57	600	180,942	17,408	Jun 06 04:52 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	May 24	Sale	296.33	250	74,082	35,175	May 25 04:44 PM
Patterson Chad	EVP Global Marketing	May 09	Sale	342.77	777	266,332	13,675	May 10 04:11 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Apr 25	Sale	439.94	250	109,985	35,425	Apr 27 05:47 PM
Patterson Chad	EVP, Global Marketing	Apr 11	Sale	498.75	776	387,030	14,452	Apr 13 04:43 PM
Regan Barry J.	EVP Global Operations	Mar 29	Sale	500.00	1,106	553,000	16,345	Mar 30 05:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience